Delirium Improvement Project Quality and Safety Leaders Meeting - - PowerPoint PPT Presentation

delirium improvement project
SMART_READER_LITE
LIVE PREVIEW

Delirium Improvement Project Quality and Safety Leaders Meeting - - PowerPoint PPT Presentation

Delirium Improvement Project Quality and Safety Leaders Meeting Friday 23 March 2018 Why is delirium a priority for SCV? Increase in serious incidents involving delirium 3rd most common hospital acquired complication in Australia


slide-1
SLIDE 1

Delirium Improvement Project

Quality and Safety Leaders Meeting Friday 23 March 2018

slide-2
SLIDE 2

Why is delirium a priority for SCV?

  • Increase in serious incidents involving delirium
  • 3rd most common hospital acquired complication in Australia
  • Associated with severe adverse events
  • Preventable in 30-40% cases
  • Recent release of Delirium Clinical Care Standard
slide-3
SLIDE 3

Delirium in Victoria

  • For Victorian patients aged over >65 years
  • For Victorian patients aged over >65 years WITH DELIRIUM

Delirium vs No delirium 8.1% Mortality 2.6% 14.9% + ICU 10.6% 15.2% + Septicaemia 10.6% 10.6 days Length of stay 5.6 3.07 WIES Cost 1.68 WIES Regional/rural Vs Metro 10.1% Mortality 6.6% 12.2 days Length of stay 9.4 days

slide-4
SLIDE 4

Prevalence

In Victoria…. Prevalence of delirium is 0.5% = 6600 observed cases In the literature… Prevalence of delirium is 11-68% = 145,200 - 897,600 observed cases 138-600 – 891,000 missed cases each year Between 30-40% of delirium cases are preventable… 11% = 43,560-58,080 preventable cases each year 68% = 269,280 – 359,040 preventable cases each year

slide-5
SLIDE 5

Delirium Improvement Project

  • 18-24 month multidisciplinary project led by Safer Care Victoria

Aim

  • To improve the screening, prevention and management of hospital acquired delirium in

Victorian public hospitals Outputs

  • SCV endorsed delirium screening tool, delirium management pathway, revised clinical

practice guideline, improvement sector forums, patient, family & clinician education resources, point prevalence survey methodology

slide-6
SLIDE 6

Pilot point prevalence survey

Primary aim To test a methodology for conducting a point prevalence survey of delirium in the Victorian public inpatient population Secondary aims To determine:

  • the prevalence of delirium and cognitive impairment
  • the difference between measured prevalence and reported prevalence
  • the characteristics of patients with or at risk of delirium
  • the frequency of physical and chemical restraint use
  • the frequency of adverse events (falls and pressure injuries)
  • Overall and by health service, hospital, ward and treating speciality
  • Patients at risk of or identified as having hospital acquired delirium
slide-7
SLIDE 7

Pilot point prevalence survey

Design

  • ‘Staggered’ point prevalence survey design
  • Study site coordinators to coordinator survey in health services
  • Surveyors recruited locally to collect data
  • Registered nurses, allied health, quality managers
  • Receive training in survey protocol and remuneration for time
  • Receive resources and support

Method

  • 4 health services, 12 hospitals, 1048 beds
  • 4 study site coordinators, 34 surveyors
  • 23 days of data collection, 6 hours per day, 0.5 hours per bed
slide-8
SLIDE 8

Pilot point prevalence survey

Secondary aims:

  • 4AT assessment tool
  • Participant observation
  • Medical record review
  • Data linkage (post hoc)
  • Paper
  • Electronic

Data sources Primary aims

Resource data

  • People, time, cost

Training evaluation

  • Study site coordinator
  • Surveyors

Role evaluation

  • Study site coordinator
  • Surveyors
slide-9
SLIDE 9

Pilot point prevalence survey

Demographics

  • Age, gender, language, Aboriginal and Torres Strait Islander, Charslon comorbidity index

Physical restraint

  • Nursing special/sitter, arm or leg shackles, mitts, bed sheets tucked/doubled/tied across

torso, posey vest or seat belt, low chair, tray table fixed to chair, bucket chair, concave mattress, both cot-sides up, bed against wall with near cot-side up Chemical restraint

  • Administered in previous 24 hours
  • Alprazolam, clonidine, haloperidol, lorazepam, olanzapine, oxazepam, quetiapine, risperidone
  • New prescription this admission
  • Stat, PRN or regular administration
  • Indication other than diagnosed psychiatric condition or pain relief
slide-10
SLIDE 10

Pilot point prevalence survey

Risk factors

  • Age
  • Known cognitive impairment
  • Current hip fracture
  • Severe medical illness – Modified Early Warning Score (Subbe et al., 2001)

Score Physiological parameter 3 2 1 1 2 3 Systolic blood pressure (mmHg) < 70 71-80 81-100 101-199 ≥ 200 Heart rate (bpm) <40 41-50 51-100 101-110 111-129 ≥ 130 Respiratory rate (bpm) < 9 9-14 15-20 21-29 ≥ 30 T emperature (ºC) < 35 35-38.4 ≥ 38.5 AVPU score A V P U

slide-11
SLIDE 11

Pilot point prevalence survey

Participants: Hospitals

slide-12
SLIDE 12

Pilot point prevalence survey

Participants: Wards/treating specialities Included Excluded Acute (medical, surgical, specialist medicine) Same-day admissions (dialysis, chemotherapy., day surgery) Sub-acute (geriatric medicine & rehabilitation) Emergency departments (short stay & urgent care centres) Palliative care wards Mental health High dependency units Paediatric Intensive care units Maternity Outlier specialities on included wards

slide-13
SLIDE 13

Pilot point prevalence survey

Participants: Patients Included Excluded In-patients Aged < 18 years Aged ≥ 18 years Physically aggressive (safety risk) Non-English speaking Too critically ill to participate Post-anaesthetic care unit transfer Severe aphasia or non verbal Isolated due to immunocompromise Comatose Intellectual disability Imminently approaching end of life Delirium tremens Undergone neurosurgical procedure ≥ C3 within 7 days

slide-14
SLIDE 14

Pilot point prevalence survey

Results

  • Public report
  • State, peer group
  • Health service report
  • Hospital, ward, treating speciality
  • Raw data for further analysis
  • Publications and presentations

Next steps

  • Data analysis for pilot study in March 2017
  • Ethics amendment April 2018
  • State-wide survey May-June 2018
slide-15
SLIDE 15

Questions